Compare ZM & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZM | ZTS |
|---|---|---|
| Founded | 2011 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1B | 31.2B |
| IPO Year | 2019 | 2012 |
| Metric | ZM | ZTS |
|---|---|---|
| Price | $105.44 | $79.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 12 |
| Target Price | $94.14 | ★ $154.18 |
| AVG Volume (30 Days) | 4.8M | ★ 9.2M |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.86% |
| EPS Growth | ★ 92.52 | 10.05 |
| EPS | 1.42 | 1.42 |
| Revenue | $4,868,769,000.00 | ★ $9,467,000,000.00 |
| Revenue This Year | $7.30 | $5.63 |
| Revenue Next Year | $3.96 | $4.77 |
| P/E Ratio | $74.79 | ★ $54.64 |
| Revenue Growth | ★ 4.36 | 2.28 |
| 52 Week Low | $69.15 | $73.82 |
| 52 Week High | $114.74 | $171.52 |
| Indicator | ZM | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 33.51 |
| Support Level | $77.91 | $73.82 |
| Resistance Level | $111.56 | $82.34 |
| Average True Range (ATR) | 4.87 | 2.63 |
| MACD | 0.12 | 1.28 |
| Stochastic Oscillator | 54.44 | 66.84 |
Zoom Communications provides a video-first communications platform that connects people through frictionless video, voice, chat, and content sharing. The company's cloud-native platform enables video experiences and connects users across various devices and locations in a single meeting. Zoom has launched a variety of communications-related solutions, including Zoom Phone and Zoom Contact Center. The firm was founded in 2011 and serves companies of all sizes from all industries around the world.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.